ABL-kinase domain point mutation as a cause of imatinib (STI571) resistance in CML patient who progress to myeloid blast crisis
| Autor: | Sacha, Tomasz, Hochhaus, Andreas, Hanfstein, Benjamin, Müller, Martin C., Rudzki, Zbigniew, Czopek, Jacek, Wolska-Smoleń, Teresa, Czekalska, Sylwia, Salamanchuk, Zoriana, Jakóbczyk, Małgorzata, Skotnicki, Aleksander B. |
|---|---|
| Zdroj: | In Leukemia Research 2003 27(12):1163-1166 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect